Adrait 2017

Study ID(s) and Acronym(s)
NCT00488007
Current Status of Trial
Completed
Study Aim
Treatment Dementia
Study Design
RCT
Blinding
No blinding
Intervention type
Non-pharmacological
Intervention
Hearing Aids (HA)
Dosage and Duration
For the first 6 months, the active group was treated with active HAs and the placebo group with inactive HAs. For the last 6 months, HAs in the placebo group were activated. Assessment was conducted at baseline, 6 months, and 12 months.
Absolute Number of Participants
51
Health Status/Diagnosis
Dementia
Primary outcomes
Behavioral and psychological symptoms // Quality of life
Key Points
"fifty-one patients were included and randomized: 22 in active group (mean NPI 17.6; mean age 83+/-6.2) and 26 in placebo group (mean NPI 25.8; mean age 82.3+/-7.2) were fitted with HAs. At 6-month follow-up, all scores worsened without significant difference between the two groups. In placebo group, activation of HAs had no effect on the change of these scores." Adrait 2017